CYTK R&D Expenses
Cytokinetics Inc · R&D Expenses
CYTK R&D Expenses
Latest reported$394.10Mperiod ending
CYTK TTM R&D Expenses ($15.04M → $394.10M)
TTM R&D Expenses
High-resolution chart · PNG
CYTK r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 394,102,000 | |
| 408,849,000 | |
| 413,165,000 | |
| 405,257,000 | |
| 390,636,000 | |
| 357,679,000 | |
| 339,408,000 | |
| 330,755,000 | |
| 328,675,000 | |
| 332,272,000 | |
| 330,123,000 | |
| 320,165,000 | |
| 300,367,000 | |
| 274,299,000 | |
| 240,813,000 | |
| 209,293,000 | |
| 194,995,000 | |
| 174,312,000 | |
| 159,938,000 | |
| 145,661,000 | |
| 121,427,000 | |
| 106,774,000 | |
| 96,951,000 | |
| 86,064,000 | |
| 82,091,000 | |
| 84,318,000 | |
| 86,125,000 | |
| 91,068,000 | |
| 92,230,000 | |
| 89,795,000 | |
| 88,385,000 | |
| 91,359,000 | |
| 94,915,000 | |
| 93,142,000 | |
| 90,296,000 | |
| 82,821,000 | |
| 75,739,000 | |
| 65,653,000 | |
| 59,898,000 | |
| 54,371,000 | |
| 48,063,000 | |
| 50,976,000 | |
| 46,398,000 | |
| 41,928,000 | |
| 41,791,000 | |
| 40,892,000 | |
| 44,426,000 | |
| 49,471,000 | |
| 51,496,000 | |
| 52,106,000 | |
| 49,450,000 | |
| 45,484,000 | |
| 40,837,000 | |
| 36,732,000 | |
| 35,643,000 | |
| 34,384,000 | |
| 34,477,000 | |
| 36,748,000 | |
| 37,182,000 | |
| 37,744,000 | |
| 38,400,000 | |
| 38,123,000 | |
| 38,012,000 | |
| 38,673,000 | |
| 38,983,000 | |
| 38,949,000 | |
| 39,840,000 | |
| 41,488,000 | |
| 45,150,000 | |
| 49,807,000 | |
| 53,950,000 | |
| 56,438,000 | |
| 56,136,000 | |
| 55,003,000 | |
| 53,387,000 | |
| 52,455,000 | |
| 51,773,000 | |
| 50,444,000 | |
| 49,224,000 | |
| 46,933,000 | |
| 43,657,000 | |
| 41,299,000 | |
| 40,570,000 | |
| 41,076,000 | |
| 41,352,000 | |
| 41,062,000 | |
| 39,885,000 | |
| 28,644,000 | |
| 19,109,000 | |
| 16,646,000 | |
| 15,042,000 |